Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 70 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

34%

24 trials in Phase 3/4

Results Transparency

3%

1 of 30 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

65Total
Not Applicable (18)
Early P 1 (10)
P 1 (5)
P 2 (8)
P 3 (4)
P 4 (20)

Trial Status

Completed30
Unknown22
Recruiting9
Active Not Recruiting3
Not Yet Recruiting3
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 30 completed trials

Clinical Trials (70)

Showing 20 of 20 trials
NCT07037511Not ApplicableRecruiting

Effects of Salbutamol in Athletes and Implications for Screening and Sports

NCT06575530Phase 4RecruitingPrimary

Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients

NCT07166640Not ApplicableCompletedPrimary

Propofol Dose-Finding for Colonoscope Insertion in Adult Patients

NCT07162805Not ApplicableCompletedPrimary

Propofol Dose-Finding for Colonoscope Insertion in Geriatric Patients

NCT06479655Phase 4RecruitingPrimary

Compare the Efficacy and Outcome Between Fentanyl and Morphine as Analgo-sedation in Mechanically Ventilated Patients

NCT05252429Phase 2Active Not RecruitingPrimary

Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma

NCT07156968Not ApplicableCompletedPrimary

Can Different Intrathecal Drugs Affect Day Case Anal Surgery Recovery Duration?

NCT06114641Phase 4Completed

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients

NCT05154201Phase 1CompletedPrimary

Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.

NCT06479720Phase 4RecruitingPrimary

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

NCT05968885Phase 4Recruiting

Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

NCT06197295Phase 4Recruiting

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

NCT06333145Phase 4RecruitingPrimary

ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults

NCT06000462Phase 4Active Not Recruiting

The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes

NCT06432309Not ApplicableCompleted

Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

NCT06342921Phase 2Completed

ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection

NCT05456113Not ApplicableWithdrawnPrimary

Topical Cannabidiol Application and Skin Vascular Reactivity

NCT06414018Not ApplicableCompletedPrimary

Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment

NCT06742606Early Phase 1Not Yet RecruitingPrimary

Efficacy of Biological Therapy in Pediatric Inflammatory Bowel Disease

NCT06562816Phase 4RecruitingPrimary

Comparing Trypsin-Chymotrypsin and Naproxen Sodium for Post-endodontic Treatment Pain

Scroll to load more

Research Network

Activity Timeline